China Market Access Pathways for Innovative Medicines Infographic
Breaking from my usual bi-weekly newsletters, I have a valuable resource for you: an infographic detailing China Market Access Pathways – a wealth of information condensed into one chart designed to empower your decision-making process.
I trust this chart will help you connect the dots as you develop China-tailored strategies and plans.
You can download the infographic here:
As you travel down the access pathways, from coverage and reimbursement to local listing, it’s crucial to consider some key questions:
- Who are the key stakeholders?
- What are the roles and perspectives of each stakeholder?
- What constitutes value to them?
- How do they make their decisions?
- What evidence is meaningful to them?
Additionally, a significant distinction between China and developed markets is that China's healthcare system is continually evolving. The government is actively implementing systemic and linkage reforms to balance medical care, medical insurance, and medicine.
This dynamic landscape means that major policy initiatives in China often have a system-wide impact. So, revisiting the above questions within the context of specific policies is critical.
- How will the policy affect key stakeholder roles, perspectives, decision-making criteria, and value preferences?
- How will it shape tomorrow's payer and provider environment?
- How might these changes influence my portfolio, key drugs, and pipeline potential?
I hope you find the infographic helpful. Happy downloading!
